July 26, 2010 / (http://www.myprgenie.com) — Medrium, Inc., a medical healthcare information technology company, today announced it has signed a partnership agreement with Micromedex Solutions from Thomson Reuters to provide evidence-based referential content to its newly released EMR.
Under terms of the agreement, Medrium will incorporate Micromedex evidence-based medication information through RED BOOK and UltiMedex. These solutions will provide data for an intuitive medication pick list featuring drug product and pricing information on all active prescription and OTC medications, proactive screenings with alerts for potential drug interactions, allergies and other medication conflicts, and patient-specific dosing covering multiple routes of administration. Additional clinical evidence is readily accessible for summary-level Micromedex drug information with ability to link directly to comprehensive drug monographs and patient education monographs covering information for chronic medications, injectable drugs, and chemotherapeutic agents in both English and Spanish.
Medrium’s Complete Practice Management solution offers an integrated suite combining practice management, clinical and billing functions in a solution for physicians’ offices, while Micromedex solutions have been primarily targeted towards the hospital.
